Bedrocan Canada is focused on clinical research, technologically-advanced, automated production processes, innovative product development, and environmentally responsible production and operation. The Company produces six strains of medical cannabis, and has two facilities in the Greater Toronto Area licensed by Health Canada under the Marihuana for Medical Purposes Regulations. Bedrocan Canada and its licensor Bedrocan Beheer BV (Netherlands) are the only companies in the world currently capable of producing standardized full-bud, pharmaceutical-grade medicinal cannabis. www.bedrocan.ca
View Top Employees from Bedrocan CanadaWebsite | https://www.bedrocan.ca |
Ticker | BED |
Revenue | $11.6 million |
Employees | 10 (8 on RocketReach) |
Founded | 2012 |
Address | 250 A Eglinton Ave. East, Toronto, Ontario M4P 3E7, CA |
Phone | (416) 943-5800 |
Fax | (416) 943-5804 |
Industry | Retail, Pharmaceuticals |
Web Rank | 21 Million |
SIC | SIC Code 62 Companies, SIC Code 621 Companies |
NAICS | NAICS Code 52399 Companies, NAICS Code 52 Companies, NAICS Code 523 Companies, NAICS Code 5239 Companies |
Looking for a particular Bedrocan Canada employee's phone or email?
The Bedrocan Canada annual revenue was $11.6 million in 2024.
Michael Rubin is the Vice-President, Marketing and BD of Bedrocan Canada.
8 people are employed at Bedrocan Canada.
Bedrocan Canada is based in Toronto, Ontario.
The NAICS codes for Bedrocan Canada are [52399, 52, 523, 5239].
The SIC codes for Bedrocan Canada are [62, 621].